News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?
Jul 29, 2024, 02:27

Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?

Leandro Jonata Oliveira, Medical Oncologist at Grupo Oncoclinicas,  shared a poll on X:

“Tapestry Study: screening using exome Sequencing identified 32% of HBOC and 56% of Lynch Syndrome carriers who did not meet NCCN criteria for genetic testing (GT).

In the scenario of unrestricted access to GT and couseling, would you recommend universal germline GT for patients with cancer?
  • Yes
  • Not
  • Not yet

‘Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations published in JCO Precision Oncology’

Autors: N. Jewel Samadder, Emily Gay, Vanda Lindpere, Michelle L. Bublitz, Lorelei A. Bandel, Sebastian M. Armasu, Robert A. Vierkant, Matthew J. Ferber, Eric W. Klee, Nicholas B. Larson, Teresa M. Kruisselbrink, Jan B. Egan, Jennifer L. Kemppainen, Jessa S. Bidwell, Jennifer L. Anderson, Tammy M. McAllister, T’Nita S. Walker, Katie L. Kunze, Michael A. Golafshar, Margaret A. Klint, Richard J. Presutti, William V. Bobo, Aleksander Sekulic, Jolene M. Summer-Bolster, Cheryl L. Willman, and Konstantinos N. Lazaridis.”

Leandro Jonata Oliveira

Source: Leandro Jonata Oliveira/X

Aleksander Sekulic cancer Cheryl L. Willman Emily Gay Eric W. Klee exome Sequencing identifies Jan B. Egan Jennifer L. Anderson Jennifer L. Kemppainen Jessa S. Bidwell Jolene M. Summer-Bolster Katie L. Kunze Konstantinos N. Lazaridis Leandro Jonata Oliveira Lorelei A. Bandel Lynch Syndrome Margaret A. Klint Matthew J. Ferber Michael A. Golafshar Michelle L. Bublitz N. Jewel Samadder NCCN Nicholas B. Larson OncoDaily Oncology Richard J. Presutti Robert A. Vierkant Sebastian M. Armasu T'Nita S. Walker Tammy M. McAllister Teresa M. Kruisselbrink Vanda Lindpere William V. Bobo
Special Coverage
Insight
Dec 22, 2024, 05:59
How the new data from ASCO GI 25 will change our practice - Oncology Brothers
Opinion
Dec 22, 2024, 05:38
BGICC 2025 Congress and Everything You Need to Know About Abstracts, Key Dates, and Deadlines
Blog
Dec 22, 2024, 05:31
Muhammad Bilal Abid: The Importance of Early Colon Cancer Screening
Blog
Dec 22, 2024, 05:28
Luis E Raez: Annual GO2 Foundation for Lung Cancer Walk/Run to raise funds and awareness
Blog
Dec 22, 2024, 05:25
Punita Khanna: Advances in breast cancer research, testing, treatment and therapies at the SABCS2024
Insight
Dec 22, 2024, 05:22
Camilla Perucchini: I have officially graduated with a Master of Science in Biotechnology curriculum
Career
Dec 22, 2024, 05:19
Sidra Naz has been honored with the 2025 Early Career Investigator Award in Healthcare Disparities Research in IBD
Blog
Dec 22, 2024, 05:17
Rasha Aboelhassan: Oncologists are overwhelmed by their own fights against cancer
Blog
Dec 22, 2024, 05:15
Jemma Arakelyan: Collaboration plans between City University of Hong Kong and Shenzhen Hospital of Southern Medical University
Blog
Dec 22, 2024, 05:13
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?